Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway
<p>Abstract</p> <p>Background</p> <p>The combined effects of anticancer drugs with nutritional factors against tumor cells have been reported previously. This study characterized the efficacy and possible mechanisms of the combination of sorafenib and vitamin K1 (VK1) o...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/60 |